Cynthia L. Monaco

Dr. Cynthia L. Monaco

University of Rochester School of Medicine and Dentistry
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Cell
Verified
Journal Article
Closed access
JNJason M. Norman
Jason M. Norman
SHScott A. Handley
Scott A. Handley
MBMegan Baldridge
Megan Baldridge
LDLindsay Droit
Lindsay Droit
CLCatherine Y. Liu
Catherine Y. Liu
HVHerbert W. Virgin
Herbert W. Virgin

1 March 2016 in Cell Host & Microbe
Verified
Journal Article
Closed access
Cynthia L. MonacoCynthia L. Monaco
Cynthia L. Monaco
DGDavid B. Gootenberg
David B. Gootenberg
GZGuoyan Zhao
Guoyan Zhao
SHScott A. Handley
Scott A. Handley
MGMusie S. Ghebremichael
Musie S. Ghebremichael
HVHerbert W. Virgin
Herbert W. Virgin

1 March 2016 in Cell Host & Microbe
Verified
Journal Article
Closed access
SHScott A. Handley
Scott A. Handley
CDChandni Desai
Chandni Desai
GZGuoyan Zhao
Guoyan Zhao
LDLindsay Droit
Lindsay Droit
Cynthia L. MonacoCynthia L. Monaco
Cynthia L. Monaco
HVHerbert W. Virgin
Herbert W. Virgin

19 February 2022 in Viruses
Verified
Journal Article
Open access
PDF file
Ferralita S MadereFerralita S Madere
Ferralita S Madere
MSMichael Sohn
Michael Sohn
AWAngelina K. Winbush
Angelina K. Winbush
BBBreóna Barr
Breóna Barr
AGAlex Grier
Alex Grier
Cynthia L. MonacoCynthia L. Monaco
Cynthia L. Monaco
The female reproductive tract (FRT) microbiome plays a vital role in maintaining vaginal health. Viruses are key regulators of other microbial ecosystems, but little is known about how the FRT viruses (virome), particularly bacteriophages that comprise the phageome, impact FRT health and dysbiosis. We hypothesize that bacterial vaginosis (BV) is associated with altered FRT phageome diversity, transkingdom interplay, and bacteriophage discriminate taxa. Here, we conducted a retrospective, longitudinal analysis of vaginal swabs collected from 54 BV-positive and 46 BV-negative South African women. Bacteriome analysis revealed samples clustered into five distinct bacterial community groups (CGs), and further, bacterial alpha diversity was significantly associated with BV. Virome analysis on a subset of baseline samples showed FRT bacteriophages clustering into novel viral state types (VSTs), a viral community clustering system based on virome composition and abundance. Distinct BV bacteriophage signatures included increased alpha diversity along with discriminant Bacillus, Burkholderia, and Escherichia bacteriophages. Bacteriophage-bacteria transkingdom associations were also identified between Bacillus and Burkholderia viruses and BV-associated bacteria, providing key insights for future studies elucidating the transkingdom interactions driving BV-associated microbiome perturbations. In this cohort, bacteriophage-bacterial associations suggest complex interactions, which may play a role in the establishment and maintenance of BV.


1 March 2015 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
CWCraig Wilen
Craig Wilen
Cynthia L. MonacoCynthia L. Monaco
Cynthia L. Monaco
JHJoan Hoppe-Bauer
Joan Hoppe-Bauer
RJRonald Jackups
Ronald Jackups
RBRobert C. Bucelli
Robert C. Bucelli
CBCarey-Ann D. Burnham
Carey-Ann D. Burnham
Excessive utilization of laboratory diagnostic testing leads to increased health care costs. We evaluated criteria to reduce unnecessary nucleic acid amplification testing (NAAT) for viral pathogens in cerebrospinal fluid (CSF) samples from adults. This is a single-center split retrospective observational study with a screening cohort from 2008 to 2012 and a validation cohort from 2013. Adults with available results for herpes simplex virus 1/2 (HSV-1/2), varicella-zoster virus (VZV), cytomegalovirus (CMV), or enterovirus (EV) NAAT with CSF samples between 2008 and 2013 were included ( n = 10,917). During this study, 1.3% ( n = 140) of viral NAAT studies yielded positive results. The acceptance criteria of >10 nucleated cells/μl in the CSF of immunocompetent subjects would have reduced HSV-1/2, VZV, CMV, and EV testing by 63%, 50%, 44%, and 51%, respectively, from 2008 to 2012. When these criteria were applied to the 2013 validation data set, 54% of HSV-1/2, 57% of VZV, 35% of CMV, and 56% of EV tests would have been cancelled. No clinically significant positive tests would have been cancelled in 2013 with this approach. The introduction of a computerized order entry set was associated with increased test requests, suggesting that computerized order sets may contribute to unnecessary testing. Acceptance criteria of >10 nucleated cells/μl in the CSF of immunocompetent adults for viral CSF NAAT assays would increase clinical specificity and preserve sensitivity, resulting in significant cost savings. Implementation of these acceptance criteria led to a 46% reduction in testing during a limited follow-up period.